Paul A. Brown

3.8k total citations
95 papers, 3.2k citations indexed

About

Paul A. Brown is a scholar working on Molecular Biology, Nephrology and Organic Chemistry. According to data from OpenAlex, Paul A. Brown has authored 95 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 15 papers in Nephrology and 13 papers in Organic Chemistry. Recurrent topics in Paul A. Brown's work include Nitric Oxide and Endothelin Effects (7 papers), Acute Kidney Injury Research (7 papers) and Renal Diseases and Glomerulopathies (7 papers). Paul A. Brown is often cited by papers focused on Nitric Oxide and Endothelin Effects (7 papers), Acute Kidney Injury Research (7 papers) and Renal Diseases and Glomerulopathies (7 papers). Paul A. Brown collaborates with scholars based in United Kingdom, United States and Italy. Paul A. Brown's co-authors include Keith N. Stewart, Salvatore Cuzzocrea, Christoph Thiemermann, Prabal K. Chatterjee, Hélder Mota‐Filipe, Nimesh S. A. Patel, Kai Zacharowski, Kevin L. Shuford, Stuart J. Shankland and Charles E. Alpers and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Angewandte Chemie International Edition.

In The Last Decade

Paul A. Brown

92 papers receiving 3.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Paul A. Brown United Kingdom 31 920 597 407 395 360 95 3.2k
Lili Fu China 25 1.5k 1.6× 675 1.1× 390 1.0× 199 0.5× 222 0.6× 86 3.2k
Tsutomu Inoue Japan 33 1.8k 2.0× 1.1k 1.8× 396 1.0× 247 0.6× 251 0.7× 185 4.9k
Anthony G.W. Norden United Kingdom 31 1.2k 1.3× 663 1.1× 236 0.6× 429 1.1× 121 0.3× 66 3.0k
Alexei G. Basnakian United States 31 1.5k 1.6× 362 0.6× 260 0.6× 227 0.6× 402 1.1× 80 3.1k
Shinichi Kawai Japan 42 1.1k 1.2× 219 0.4× 424 1.0× 328 0.8× 1.3k 3.7× 181 6.4k
Masashi Nishida Japan 26 733 0.8× 223 0.4× 286 0.7× 357 0.9× 320 0.9× 87 2.2k
Joseph P. Gaut United States 29 1.1k 1.2× 664 1.1× 611 1.5× 431 1.1× 749 2.1× 72 3.3k
Shuxia Wang China 33 1.9k 2.1× 235 0.4× 603 1.5× 579 1.5× 691 1.9× 154 4.7k
Vera Jankowski Germany 33 1.3k 1.4× 900 1.5× 425 1.0× 455 1.2× 232 0.6× 133 3.6k
Jean‐Loup Bascands France 35 1.9k 2.0× 718 1.2× 452 1.1× 313 0.8× 536 1.5× 155 4.7k

Countries citing papers authored by Paul A. Brown

Since Specialization
Citations

This map shows the geographic impact of Paul A. Brown's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul A. Brown with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul A. Brown more than expected).

Fields of papers citing papers by Paul A. Brown

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul A. Brown. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul A. Brown. The network helps show where Paul A. Brown may publish in the future.

Co-authorship network of co-authors of Paul A. Brown

This figure shows the co-authorship network connecting the top 25 collaborators of Paul A. Brown. A scholar is included among the top collaborators of Paul A. Brown based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul A. Brown. Paul A. Brown is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Brown, Paul A., et al.. (2024). Enhancing Charge Transport Using Boron and Nitrogen Substitutions into Triphenylene-Based Discotic Liquid Crystals. The Journal of Physical Chemistry B. 128(14). 3463–3474.
2.
Brown, Paul A., et al.. (2023). Induction of experimental diabetes and diabetic nephropathy using anomer-equilibrated streptozotocin in male C57Bl/6J mice. Biochemical and Biophysical Research Communications. 650. 109–116. 9 indexed citations
3.
Brown, Paul A., et al.. (2022). Insertion of the Liquid Crystal 5CB into Monovacancy Graphene. Molecules. 27(5). 1664–1664. 4 indexed citations
4.
Brown, Paul A., et al.. (2019). Thermotropic liquid crystal (5CB) on two-dimensional materials. Physical review. E. 100(6). 13 indexed citations
5.
Brown, Paul A. & Kevin L. Shuford. (2016). Archimedean (4,8)-tessellation of haeckelite ultrathin nanosheets composed of boron and aluminum-group V binary materials. Nanoscale. 8(46). 19287–19301. 13 indexed citations
6.
Barnard, Jonathan H., Paul A. Brown, Kevin L. Shuford, & Caleb D. Martin. (2015). 1,2‐Phosphaborines: Hybrid Inorganic/Organic P–B Analogues of Benzene. Angewandte Chemie International Edition. 54(41). 12083–12086. 66 indexed citations
7.
Browne, Gemma, Paul A. Brown, Charles Tomson, et al.. (2004). Retransplantation in Alport post-transplant anti-GBM disease. Kidney International. 65(2). 675–681. 34 indexed citations
8.
Sivarajah, Ahila, Prabal K. Chatterjee, Nimesh S. A. Patel, et al.. (2003). Agonists of Peroxisome-Proliferator Activated Receptor-Gamma Reduce Renal Ischemia/Reperfusion Injury. American Journal of Nephrology. 23(4). 267–276. 128 indexed citations
9.
Thiemermann, Christoph, Nimesh S. A. Patel, Espen Ø. Kvale, et al.. (2003). High Density Lipoprotein (HDL) Reduces Renal Ischemia/Reperfusion Injury. Journal of the American Society of Nephrology. 14(7). 1833–1843. 68 indexed citations
10.
Chatterjee, Prabal K., Nimesh S. A. Patel, Espen Ø. Kvale, et al.. (2003). The tyrosine kinase inhibitor tyrphostin AG126 reduces renal ischemia/reperfusion injury in the rat. Kidney International. 64(5). 1605–1619. 17 indexed citations
11.
Chatterjee, Prabal K., Nimesh S. A. Patel, Ahila Sivarajah, et al.. (2003). GW274150, a potent and highly selective inhibitor of iNOS, reduces experimental renal ischemia/reperfusion injury. Kidney International. 63(3). 853–865. 129 indexed citations
12.
Wen, Min, Stephan Segerer, Márcio Dantas, et al.. (2002). Renal Injury in Apolipoprotein E–Deficient Mice. Laboratory Investigation. 82(8). 999–1006. 101 indexed citations
13.
Stewart, Keith N., Peter J. Wilson, Heather M. Wilson, et al.. (2001). Thy1 Glomerulonephritis Induced in Young Lewis Rats Accelerates Age-Related Glomerulosclerosis. ˜The œNephron journals/Nephron journals. 88(1). 57–64. 3 indexed citations
14.
Wilson, Heather M., Andrew W. Minto, Paul A. Brown, Lars‐Peter Erwig, & Andrew J. Rees. (2000). Transforming growth factor-β isoforms and glomerular injury in nephrotoxic nephritis. Kidney International. 57(6). 2434–2444. 22 indexed citations
15.
Hillis, Graham S., et al.. (1997). Upregulation and co-localization of connexin43 and cellular adhesion molecules in inflammatory renal disease. The Journal of Pathology. 182(4). 373–379. 41 indexed citations
16.
Whiting, P. H. & Paul A. Brown. (1996). The Relationship Between Enzymuria and Kidney Enzyme Activities in Experimental Gentamicin Nephrotoxicity. Renal Failure. 18(6). 899–909. 60 indexed citations
17.
Stewart, Keith N., Graham S. Hillis, Prabir Roy‐Chaudhury, et al.. (1995). Integrin distribution in normal kidney and cultured human glomerular cells.. PubMed. 3(2). 140–1. 2 indexed citations
18.
Briggs, Andrew, et al.. (1994). Effects of additional stereogenic centres and cation in the nucleophilic epoxidation of vinylsulfoximines with metal alkylperoxides. Tetrahedron Letters. 35(37). 6945–6948. 16 indexed citations
19.
N’Dow, James, et al.. (1993). Inflammatory Pseudotumour of the Urinary Bladder. British Journal of Urology. 72(3). 379–380. 9 indexed citations
20.
Brown, Paul A., et al.. (1993). Alleviation of experimental cyclosporin A nephrotoxicity by low dose aspirin in the rat. Biochemical Pharmacology. 46(11). 2104–2108. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026